Focus: Aria CV is a medical device biotechnology company focused on pulmonary arterial hypertension (PAH) treatment through innovative device-based systems. The company operates as a public entity headquartered in St. Paul, Minnesota.
Profile data last refreshed 6h ago · AI intelligence enriched 2w ago
Aria CV is a niche-focused device biotech play suited for specialists seeking rare-disease impact and technical depth, but with opacity around financial health and limited pipeline maturity.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Aria CV
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Aria CV's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo